Kering Reports Lacklustre Q1 Revenues in First Quarter without Beauty

Why It Matters

The results underscore how the divestiture of Kering’s beauty arm and geopolitical tensions are reshaping earnings for a leading luxury conglomerate, influencing investor sentiment and future growth pathways.

Key Takeaways

• Kering Q1 revenue fell 6% to €3.5bn ($3.8bn).
• Wholesale sales rose 6% driven by eyewear growth.
• Gucci revenue dropped 14% reported, 8% comparable.
• Middle East conflict cut regional retail revenue 11%.
• Beauty unit sale to L’Oréal valued at €4bn ($4.4bn).

Pulse Analysis

Kering’s first‑quarter report illustrates the growing pains of a luxury powerhouse adjusting to a major strategic shift. The €4 bn ($4.4 bn) sale of its beauty division to L’Oréal removed a historically profitable segment, leaving the group to rely more heavily on fashion, leather goods and accessories. Consequently, total revenue slipped to €3.5 bn ($3.8 bn), a 6 % decline that reflects both the loss of beauty‑related sales and a broader slowdown in consumer spending across Europe and Asia. Analysts note that the timing of the divestiture, coinciding with heightened geopolitical risk, amplifies the earnings impact and raises questions about the pace of Kering’s recovery.

Despite the headline decline, the quarter revealed pockets of resilience. Wholesale channels grew 6 % on a comparable basis, buoyed by robust demand for eyewear—a category that benefits from both fashion cycles and functional use. Jewellery sales also contributed positively, aligning with a consumer trend toward high‑value, timeless pieces. North America emerged as a bright spot for Gucci, posting an 8 % year‑on‑year increase, while the Middle East market suffered an 11 % drop in retail revenue as conflict disrupted tourism and local spending. These divergent regional dynamics highlight the importance of a diversified geographic footprint for luxury brands navigating macro‑economic headwinds.

Looking ahead, Kering’s partnership with L’Oréal on a joint venture focused on wellness and longevity science could offset some of the lost beauty revenue, positioning the group at the intersection of luxury and health‑tech. Additionally, the upcoming 50‑year exclusive licence for Gucci fragrance and beauty products, slated to begin after the current Coty agreement ends in 2028, offers a long‑term revenue stream once fully operational. Investors will be watching how quickly Kering can translate these strategic initiatives into top‑line growth while managing the lingering effects of geopolitical instability on global tourism and consumer confidence.